Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Locked vault There are a number of factors that work against a more efficient drug distribution system, including industry privacy agreements that mask financial incentives. (Image: Shutterstock)

The current supply chain for pharmaceuticals has built-in incentives to include low-value, high-cost drugs, a new study finds. For employer-sponsored plans and other purchasers, wasteful spending on such drugs represent significant costs that could be reduced if purchasers pushed for more efficiency.


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.